Skip to content

Trevi Therapeutics, Inc. TRVI Other Non-Current Assets

Other Non-Current Assets at other companies

Indivior Pharmaceuticals, Inc.
 logo
Indivior Pharmaceuticals, Inc. INDV
$26M-33.3%
LQD
Liquidia CorporationLQDA
$16.9M+8.7%
United Therapeutics logo
United TherapeuticsUTHR
$233.2M+4.9%

Other financials

Income statement

See full
Operating income-$14.9M-30.0%
Net income-$13.2M-27.6%
EPS (diluted)-$0.090.0%

Balance sheet

See full
Cash & equivalents$19.4M+0.2%
Total debt$682.0K-28.7%
Total equity$172.1M+73.1%
Total assets$179.6M+67.8%

Cash flow

See full
Operating cash flow-$16.7M-23.8%
CapEx$102.0K
Free cash flow-$16.8M

Valuation

See full
Market cap$2.47B+152%
Enterprise value$2.45B+157%

Returns & leverage

See full
Return on equity-33.6%-9.4pp
Debt / equity0.0×
Current ratio24.8×+9.4×

Where this comes from

Reported directly by Trevi Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Trevi Therapeutics, Inc.'s other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Trevi Therapeutics, Inc.'s other non-current assets?
Trevi Therapeutics, Inc. (TRVI) reported other non-current assets of $2.61M in Q1 2026.
How has Trevi Therapeutics, Inc.'s other non-current assets changed year-over-year?
Trevi Therapeutics, Inc.'s other non-current assets increased by 983.0% year-over-year, from $241K to $2.61M.
What is the long-term trend for Trevi Therapeutics, Inc.'s other non-current assets?
Over 5 years (2020 to 2025), Trevi Therapeutics, Inc.'s other non-current assets has grown at a 11.8% compound annual growth rate (CAGR), from $532K to $928K.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.